DE60139409D1 - Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen - Google Patents

Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen

Info

Publication number
DE60139409D1
DE60139409D1 DE60139409T DE60139409T DE60139409D1 DE 60139409 D1 DE60139409 D1 DE 60139409D1 DE 60139409 T DE60139409 T DE 60139409T DE 60139409 T DE60139409 T DE 60139409T DE 60139409 D1 DE60139409 D1 DE 60139409D1
Authority
DE
Germany
Prior art keywords
derivative
treatment
dibenococyclooctanlignane
prevention
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60139409T
Other languages
English (en)
Inventor
Young-Joong Kim
Sang-Hyun Sung
Mi-Gyeong Lee
So-Ra Kim
Gyeong-A Gu
Won-Ju Jeong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elcom Bio Technology Co Ltd
Original Assignee
Elcom Bio Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elcom Bio Technology Co Ltd filed Critical Elcom Bio Technology Co Ltd
Application granted granted Critical
Publication of DE60139409D1 publication Critical patent/DE60139409D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60139409T 2000-10-19 2001-10-19 Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen Expired - Fee Related DE60139409D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0061676A KR100380634B1 (ko) 2000-10-19 2000-10-19 디벤조사이클로옥탄계 리그난 화합물을 포함하는 퇴행성 뇌신경계 질환의 예방 또는 치료용 조성물
PCT/KR2001/001765 WO2002032417A1 (en) 2000-10-19 2001-10-19 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease

Publications (1)

Publication Number Publication Date
DE60139409D1 true DE60139409D1 (de) 2009-09-10

Family

ID=19694389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139409T Expired - Fee Related DE60139409D1 (de) 2000-10-19 2001-10-19 Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen

Country Status (9)

Country Link
US (1) US6653344B2 (de)
EP (1) EP1326596B1 (de)
JP (1) JP3996505B2 (de)
KR (1) KR100380634B1 (de)
CN (1) CN1171585C (de)
AT (1) ATE437636T1 (de)
AU (1) AU2002214336A1 (de)
DE (1) DE60139409D1 (de)
WO (1) WO2002032417A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032443A1 (en) * 2000-10-19 2002-04-25 Elcom Bio Technology, Co., Ltd. Saururus chinensis extract for prevention and treatment of neurodegenerative disease
KR100569089B1 (ko) * 2002-07-20 2006-04-10 주식회사 엘컴사이언스 뇌기능 및 인지 기능 개선 활성을 갖는 조성물
KR100679306B1 (ko) 2005-03-31 2007-02-06 아미코젠주식회사 리그난계 화합물을 함유하는 뇌신경질환의 치료 또는예방용 약학적 조성물
KR100752750B1 (ko) * 2005-07-11 2007-08-29 최영환 오미자로부터 추출된 쉬산드렌 및 이를 주성분으로 한 항산화제 조성물
KR100781581B1 (ko) 2006-05-11 2007-12-03 김호철 신경보호 활성을 갖는 오미자로부터 분리한 고미신 a를유효성분으로 함유하는 약학 조성물
EP2025335A1 (de) * 2007-08-16 2009-02-18 InterMed Discovery GmbH Extrakte mit Leber-X-Rezeptormodulatoren, Verbindungen und ihre Verwendung bei der Kontrolle und Behandlung von Störungen des Lipid-Stoffwechsels
WO2012045400A1 (en) * 2010-10-05 2012-04-12 Cognis Ip Management Gmbh An extract of the fruit of the plant schisandra chinensis
CN104151373B (zh) * 2013-05-13 2017-01-18 四川万安石斛产业开发有限公司 一种木脂素苷类化合物及其制备方法
CN106939009A (zh) * 2017-03-31 2017-07-11 牡丹江医学院 一种用于治疗脑震荡的药物及其制备方法
KR102147794B1 (ko) 2018-11-12 2020-08-25 서울대학교 산학협력단 토마토 추출물 및 레몬 추출물의 혼합물을 포함하는 신경퇴행성질환 치료용 조성물
CN115919837A (zh) * 2022-08-17 2023-04-07 浙江中医药大学 戈米辛n在制备缺血性脑中风治疗药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6222714A (ja) * 1985-07-22 1987-01-30 Tsumura Juntendo Inc 脂質代謝促進剤
JPS6416721A (en) * 1987-07-09 1989-01-20 Tsumura & Co Antioxidant
JPS6442421A (en) * 1987-08-10 1989-02-14 Tsumura & Co Calcium antagonistic agent
JPH01316313A (ja) * 1988-03-17 1989-12-21 Tsumura & Co 脳機能改善薬

Also Published As

Publication number Publication date
KR100380634B1 (ko) 2003-04-26
JP2004511514A (ja) 2004-04-15
US20030050335A1 (en) 2003-03-13
KR20020030642A (ko) 2002-04-25
EP1326596B1 (de) 2009-07-29
CN1171585C (zh) 2004-10-20
AU2002214336A1 (en) 2002-04-29
US6653344B2 (en) 2003-11-25
EP1326596A4 (de) 2005-11-23
EP1326596A1 (de) 2003-07-16
WO2002032417A1 (en) 2002-04-25
JP3996505B2 (ja) 2007-10-24
ATE437636T1 (de) 2009-08-15
CN1394137A (zh) 2003-01-29

Similar Documents

Publication Publication Date Title
HUP0105437A2 (hu) Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
UY27368A1 (es) Nuevos compuestos
CA2401229A1 (en) Aryl fused azapolycyclic compounds
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
ME00595B (me) 2-okso-1-pirolidinski derivati, postupci za njihovo dobijanje i njihove primene
MA26956A1 (fr) Pyrimidine-2,4,6,triones inhibitrices de metalloproteinases.
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
NO20074657L (no) Nitrogenholdige aromatiske ringforbindelser
MXPA01006474A (es) Derivados colquinol como agentes perjudiciales vasculares.
HUP0000838A2 (hu) Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények
MEP9509A (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
UA74391C2 (uk) Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти
NZ284846A (en) 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
BR0312232A (pt) Inibidores de caspases e seus usos
GEP20053459B (en) New Thiadiazoles and Oxidiazoles and Their Use as Phosphodiesterase-7 Inhibitors
GEP20022824B (en) Antipicornaviral Compounds, Pharmaceutical Compositions Containing the Same and Methods for Treatment
MA27887A1 (fr) Dicetopiperazines substituees et leur utilisation comme antagonistes de l'ocytocine
DE69811905D1 (de) Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
MA26701A1 (fr) PYRAZOLOPYRIMIDINONES NOUVELLES INHIBITRICES DE PDE-5 GMPc, PROCEDE POUR LEUR PREPARATION ET COMPOSTIONS PHARMACEUTIQUES LES CONTENANT.
DE60139409D1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
UY27593A1 (es) Nuevos compuestos
ATE312815T1 (de) Neue verbindungen
GEP20053617B (en) Bridged Piperazine Derivatives

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee